SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Mylan Inc. – ‘8-K/A’ for 2/18/03

On:  Wednesday, 2/26/03, at 6:56pm ET   ·   As of:  2/27/03   ·   For:  2/18/03   ·   Accession #:  69499-3-26   ·   File #:  1-09114

Previous ‘8-K’:  ‘8-K/A’ on 2/26/03 for 2/18/03   ·   Next:  ‘8-K’ on 5/9/03 for 3/31/03   ·   Latest:  ‘8-K’ on / for 3/2/15

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size

 2/27/03  Mylan Inc.                        8-K/A:5     2/18/03    2:3.8M

Amendment to Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K/A       Mylan Laboratories Inc. Investor Presentation       HTML      9K 
 2: EX-99       Investor Presentation                               HTML      8K 


8-K/A   —   Mylan Laboratories Inc. Investor Presentation


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  Mylan Laboratories Inc.  

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K/A

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934


February 18, 2003 (February  18, 2003)
_____________________________________

Date of Report (Date of Earliest Event Reported)



Mylan Laboratories Inc.

(Exact name of registrant as specified in its charter)






             
Pennsylvania     1-9114     25-1211621
(State or other
jurisdiction of
incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)
             
130 7th Street, Suite 1030
Pittsburgh, Pennsylvania
        15222
(Address of principal executive offices)         (Zip Code)

(412) 232-0100

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

 












Item 5. Other Events.

         A copy of Mylan Laboratories Inc. Investor Presentation is attached as exhibit 99.1.

Item 7. Financial Statements and Exhibits.

     (c)     Exhibits.

              99.1   Powerpoint presentation dated February 18, 2003.


SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

          MYLAN LABORATORIES INC.          

          By:   /s/ Robert J. Coury          
                 Robert J. Coury           
                 Vice Chairman and C.E.O.           

DATE:   February 26, 2003
Pittsburgh, Pennsylvania


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K/A’ Filing    Date    Other Filings
Filed as of:2/27/03
Filed on:2/26/038-K/A
For Period End:2/18/034,  8-K,  8-K/A
 List all Filings 
Top
Filing Submission 0000069499-03-000026   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 7:22:22.2pm ET